Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management].
Bellocq JP, Luporsi E, Barrière J, Bonastre J, Chetritt J, Le Corroller AG, de Crémoux P, Fina F, Gauchez AS, Kassab-Chahmi D, Lamy PJ, Martin PM, Mazouni C, Peyrat JP, Romieu G, Verdoni L, Mazeau-Woynar V. Bellocq JP, et al. Among authors: barriere j. Ann Pathol. 2014 Oct;34(5):349-51. doi: 10.1016/j.annpat.2014.04.010. Epub 2014 Aug 22. Ann Pathol. 2014. PMID: 25439987 French.
[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management].
Luporsi E, Bellocq JP, Barrière J, Bonastre J, Chetritt J, Le Corroller AG, de Cremoux P, Fina F, Gauchez AS, Lamy PJ, Martin PM, Mazouni C, Peyrat JP, Romieu G, Verdoni L, Mazeau-Woynar V, Kassab-Chahmi D; Institut National du Cancer. Luporsi E, et al. Among authors: barriere j. Bull Cancer. 2015 Sep;102(9):719-29. doi: 10.1016/j.bulcan.2015.05.003. Epub 2015 Jul 30. Bull Cancer. 2015. PMID: 26235416 Free article. French. No abstract available.
Prognostic factors in 401 elderly women with metastatic breast cancer.
Follana P, Barrière J, Chamorey E, Largillier R, Dadone B, Mari V, Hannoun-Levi JM, Marcy M, Flipo B, Ferrero JM. Follana P, et al. Among authors: barriere j. Oncology. 2014;86(3):143-51. doi: 10.1159/000357781. Epub 2014 Feb 26. Oncology. 2014. PMID: 24577186
Prognostic factors in 1,038 women with metastatic breast cancer.
Largillier R, Ferrero JM, Doyen J, Barriere J, Namer M, Mari V, Courdi A, Hannoun-Levi JM, Ettore F, Birtwisle-Peyrottes I, Balu-Maestro C, Marcy PY, Raoust I, Lallement M, Chamorey E. Largillier R, et al. Among authors: barriere j. Ann Oncol. 2008 Dec;19(12):2012-9. doi: 10.1093/annonc/mdn424. Epub 2008 Jul 17. Ann Oncol. 2008. PMID: 18641006 Free PMC article.
A phase I study of UFT-oral vinorelbine in metastatic breast cancer.
Ferrero JM, Largillier R, Michel C, Amiot V, Milano G, Hébert C, Mari V, Courdi A, Figl A, Follana P, Barrière J, Chamorey E. Ferrero JM, et al. Among authors: barriere j. Oncology. 2011;81(2):73-8. doi: 10.1159/000330770. Epub 2011 Sep 30. Oncology. 2011. PMID: 21968516 Clinical Trial.
Angiogenesis and tumor microenvironment: bevacizumab in the breast cancer model.
Trédan O, Lacroix-Triki M, Guiu S, Mouret-Reynier MA, Barrière J, Bidard FC, Braccini AL, Mir O, Villanueva C, Barthélémy P. Trédan O, et al. Among authors: barriere j. Target Oncol. 2015 Jun;10(2):189-98. doi: 10.1007/s11523-014-0334-9. Epub 2014 Sep 5. Target Oncol. 2015. PMID: 25185646 Review.
Bevacizumab: A dose review.
Falk AT, Barrière J, François E, Follana P. Falk AT, et al. Among authors: barriere j. Crit Rev Oncol Hematol. 2015 Jun;94(3):311-22. doi: 10.1016/j.critrevonc.2015.01.012. Epub 2015 Feb 7. Crit Rev Oncol Hematol. 2015. PMID: 25703583 Review.
91 results